An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure-Reference-Cited by-同舟云学术

An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure

Published:2024-03 Issue:3 Volume:5 Page:101448
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Liu Wei,You Wenhua,Lan Zhenwei,Ren Yijiu,Gao Shuangshu,Li Shuchao,Chen Wei-Wei,Huang Chunyu,Zeng Yong,Xiao Nengming,Wang Zeshuai,Xie Huikang,Ma Huan,Chen Yun,Wang Guangsuo,Chen Chang,Li Hanjie

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference68 articles.

1. Hallmarks of Cancer: The Next Generation;Hanahan;Cell,2011

2. Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion;Schreiber;Science,2011

3. The lung microenvironment: an important regulator of tumour growth and metastasis;Altorki;Nat. Rev. Cancer,2019

4. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer;Tian;Signal Transduct. Target. Ther.,2022

5. Spatially organized multicellular immune hubs in human colorectal cancer;Pelka;Cell,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non–Small Cell Lung Cancer. An Official American Thoracic Society Research Statement;American Journal of Respiratory and Critical Care Medicine;2024-09-01

3. Analyzing the Spatial Distribution of Immune Cells in Lung Adenocarcinoma;Journal of Personalized Medicine;2024-08-30

4. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28

5. Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial;Nature Communications;2024-08-22